Sequential re-rating: management describes the same offering landing bigger the second and third time around
The model's full reasoning — Q2 2017 call → NOWe need to determine if management describes successive engagements of the same kind coming in at progressively larger size. Look for comparisons against own past, real and recurring, early stage. Scan transcript for statements about deal size, order size, customer commitments, etc. Kishore mentions: "we have broadened our operating engagements for last mile access that have already contributed meaningfully to Q2 revenue." Not about size. "we are at the early stages of new platform growth drivers in the form of force-touch solution to the smartphones and power modules into Tier 1 Intel Purley base servers." Not about size. "we are excited to have commenced shipments of our organically developed microwave backhaul 28 nanometer CMOS RF transceiver spanning 5 Gigahertz to 45 Gigahertz frequencies. We are increasingly confident that our backhaul RF transceiver will be a growth driver in 2018 and beyond." Not about size. "we have commenced shipments of our technology leading multi-gigabit MOCA 2.5 and near gigabit Wave-2 G.hn solutions." Not about size. "we are at the early stages of new platform growth drivers" - not about size. Look for phrases like "larger", "bigger", "broader", "more than before", "initial commitments", "full deployments" etc. Adam Spice: "we have begun deleveraging having made $30 million in prepayments" - not about deals. "we are pleased to report a very busy and eventful Q2 2017, one of which we continued our sequential revenue growth while closing two strategic acquisitions" - not about size. No mention of average deal size increasing, customers starting at higher levels, etc. There is mention of "initial ramp of G.Now solutions into a major Asian telco operator" and "secular design win for G.Now last mile access at a major telco operator in Asia, which will ramp to revenues in the second half of 2018." That's about a design win, not about size escalation. "we have broadened our operating engagements for last mile access" - could be broader scope? But not explicitly comparing to past size. "we are not only garnering interest - increased interest from the traditional coaxial cable satellite and cable operators, but also for media telco broadband players in North America, Europe and China." - more interest, not size.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| SGRY | Surgery Partners, Inc. | Q2 2022 | 2022-08-02 | B+ |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
AKYA · Q2 2023 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing a clear pattern of escalating project sizes in the translational/clinical space. Brian notes a migration from exploratory studies (reasonable size) to larger retrospective studies and even larger retrospective-prospective ongoing clinical studies, with projects moving "further and further downstream.
ASAN · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES Management describes exactly this pattern. Dustin notes the company is “closing larger deals and expanding seats across departments and geographies quickly in large organizations,” and that the growth in the >$50k cohort “reflected an acceleration in our largest enterprise customers.
SGRY · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing exactly this pattern for physician recruiting cohorts. Wayne notes that the 2022 cohorts are “no exception to this trend, bringing more cases with a higher overall net revenue per case than our 2021 cohorts did in the same period last year.